Sodium-channel defects in benign familial neonatal-infantile seizures

Sarah E Heron1, Kathryn M Crossland, Eva Andermann

  • 1Department of Laboratory Genetics, Women's and Children's Hospital, North Adelaide, South Australia, Australia. sheron@bionomics.com.au

Lancet (London, England)
|September 24, 2002
PubMed

Insights

Mutations in the sodium-channel gene SCN2A cause a new epilepsy syndrome, benign familial neonatal-infantile seizures. This discovery identifies a genetic cause for early-infancy seizures, previously lacking a molecular explanation.

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Ion-channel gene defects are linked to paroxysmal disorders, including monogenic epilepsy syndromes.
  • Two early-onset autosomal dominant epilepsy syndromes exist: benign familial neonatal seizures (potassium-channel defects) and benign familial infantile seizures (unknown genes).

Purpose of the Study:

  • To identify the genetic cause of a clinically intermediate epilepsy syndrome, benign familial neonatal-infantile seizures.
  • To establish a clinico-molecular correlation for this new epilepsy syndrome.

Main Methods:

  • Clinical evaluation of patients with benign familial neonatal-infantile seizures.
  • Genetic analysis focusing on sodium-channel subunit genes, specifically SCN2A.

Main Results:

  • Mutations in the sodium-channel subunit gene SCN2A were identified in patients with benign familial neonatal-infantile seizures.
  • This finding establishes SCN2A mutations as a cause of this specific epilepsy syndrome.

Conclusions:

  • A new benign familial epilepsy syndrome, benign familial neonatal-infantile seizures, is defined by SCN2A mutations.
  • This discovery provides a molecular basis for early-infancy seizures, a period often associated with poor prognosis.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus.
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...